Stabil stenokardiya metabolik assotsirlangan jigar yog‘li kasalligi bilan kechganda MELD ko‘rsatkichi va noninvaziv diagnostika Usullarining ahamiyati
Litsenziya: cc-by
Annotatsiya
Objective: To assess the dynamics of the MELD score and Fatty Liver Index (FLI) in patients with stable exertional angina associated with metabolic dysfunction-associated fatty liver disease (MAFLD) before and after coronary artery bypass grafting (CABG). Methods: A total of 100 patients with MAFLD and stable angina (main group) and 20 patients without liver pathology (control group) were examined. All patients underwent CABG. Results: In the main group, a significant increase in MELD scores was observed after CABG, remaining higher than in the control group for up to 6 months. Hepatoprotective therapy (Heptral) significantly improved MELD indicators. Conclusion: It is necessary to assess liver function after CABG and use Heptral therapy in patients with MAFLD.